
Gilead: Buy For Dividend, HIV And Cancer Therapies (NASDAQ:GILD)
Justin Sullivan/Getty Images News Gilead Sciences (NASDAQ:GILD) has long been a leader in HIV/AIDS therapies as well as other anti-viral therapies. This last year it has seen a bolus of revenue and profits from its […]